New Alzheimer’s drug development uses AI, directed evolution, and fermentation.

A new study showed how AI machine learning can help improve enzyme design for the synthesis of galantamine.

Galantamine is a drug that may help improve the cognitive ability of patients diagnosed with dementia. machine learning can help guide and improve enzyme design for the synthesis of galantamine, a drug used to treat patients withand Alzheimer's disease. This study demonstrates the powerful potential of the combination of AI and directed evolution in the industrial-scale production of important medications in the future.

Galantamine may help improve the cognitive ability of patients diagnosed with dementia or Alzheimer’s by slowing the breakdown of acetylcholine, a neurotransmitter that plays a key role in learning andby Paul Francis. Galantamine, the generic drug for Razadyne™, Reminyl™, and Nivalin®, is a small molecule capable of crossing the blood-brain barrier that has been approved by the U.S.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Scientists Develop Potential New Method To Halt Progression of Alzheimer’s DiseaseScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

Earliest-yet Alzheimer's biomarker found in mouse model could point to new targetsA surge of a neural-specific protein in the brain is the earliest-yet biomarker for Alzheimer's disease, report researchers studying a mouse model of the disease.
Source: ScienceDaily - 🏆 452. / 53 Read more »